AgriBusiness Global Staff

The Latin American market is a thriving hub for agribusiness, offering immense opportunities for growth and partnership.

Both companies believe partnership will greatly enhance nutrient delivery to specialty crops and row crops in Latin America.

The assets will be integrated into Ginkgo Ag Biologicals Services, established with the acquisition of a Bayer agricultural biologicals R&D facility in 2022.

Futureco Bioscience CEO Rafael Juncosa discusses the future of biostimulants and the factors that will lead to growth in this market segment.

Li presented crucial information for understanding China’s crop protection manufacturers strategies for dealing with oversupply in the market.

Executives from leading biologicals companies share their insights on a wide range of prevailing topics for this year.

Explore the complexities of international trade challenges within the People’s Republic of China with insight from contributor Jim DeLisi.

Learn more about the new global brand that will represent and unify all the emerging industry segments of crops grown in controlled environments.

Chinese agrochemicals companies face a crucial decision between two strategies, says contributor David Li.

Kynetec’s Jordan Le Roux shares what regenerative ag really means and the numbers behind the trend.

The company’s first target is the Palmer amaranth weed, a major nuisance in the U.S., Brazil, and Argentina.

As Chinese pesticide producers strengthened financially, they are augmenting their investment in research and development.

Industry leaders shares strategic considerations for businesses looking to sell into China.

China’s contract research organizations industry, initially serving international pharmaceutical firms, has expanded to agrochemicals.

As you face challenges in the crop protection, biologicals, and plant health markets, we get your questions answered from industry leaders.

The May event will bring together the leaders and innovators in LATAM who are at the forefront of this new generation of agriculture.

Discover how China’s regulatory framework aims to encourage the responsible use of biologicals, promoting a greener and healthier future.

Activity continues as companies look to expand their offerings and opportunities.

There is potential for the country to emerge as a leading manufacturer of biologicals for global markets in the future.

China is making significant strides in expanding its commercial trial plantings of GM corn and soybeans.